The mapping of the magnetic field by measuring or imaging the spatial distribution of magnetic field strength, can be performed by scanning with a probe and handles a large range of field strengths, but is slow and tedious. Accurate field maps can be made by measuring the Larmor frequency as a function of position.
The field must be homogeneous enough to allow MR imaging to be performed, than the magnetic field can be mapped by different methods.
1. The adaptation of chemical shift imaging.
2. The faster one measures the change in signal phase in an image obtained with a gradient echo pulse sequence resulting from a change in echo time TE, which is proportional to the local field strength.
Also useful is a spin echo pulse sequence with data collection from two time locations of the readout gradient and the data acquisition interval, where each having a known shift of the acquisition center away from the spin echo.

This line specifies the perimeter around a MR scanner within which the static magnetic fields are higher than five gauss. Five gauss and below are considered 'safe' levels of static magnetic field exposure for the general public.
Portable devices requiring a separation distance between the device and the MR magnet, should not be considered 'MR Safe', 'MR Compatible', or intended for use in the MR environment. Typically the 5 gauss line is the only location where the static magnetic field strength is specified around a MR scanner. Therefore, labeling specifying a separation distance between the MR magnet and the device to ensure safe or proper operation of the device should be avoided.

See also the related poll result: 'In 2010 your scanner will probably work with a field strength of'

From Hitachi Medical Systems America Inc.;
the AIRIS II, an entry in the diagnostic category of open MR systems, was designed by Hitachi Medical Systems America Inc. (Twinsburg, OH, USA) and Hitachi Medical Corp. (Tokyo) and is manufactured by the Tokyo branch. A 0.3 T field-strength magnet and phased array coils deliver high image quality without the need for a tunnel-type high-field system, thereby significantly improving patient comfort not only for claustrophobic patients.

In the last years, cardiac MRI techniques have progressively improved. No other noninvasive imaging modality provides the same degree of contrast and temporal resolution for the assessment of cardiovascular anatomy and pathology. Contraindications MRI are the same as for other magnetic resonance techniques.
The primary advantage of MRI is extremely high contrast resolution between different tissue types, including blood. Moreover, MRI is a true 3 dimensional imaging modality and images can be obtained in any oblique plane along the true cardiac axes while preserving high temporal and spatial resolution with precise demonstration of cardiac anatomy without the administration of contrast media.
Due to these properties, MRI can precisely characterize cardiac function and quantify cavity volumes, ejection fraction, and left ventricular mass. In addition, cardiac MRI has the ability to quantify flow (see flow quantification), including bulk flow in vessels, pressure gradients across stenosis, regurgitant fractions and shunt fractions. Valve morphology and area can be determined and the severity of stenosis quantified. In certain disease states, such as myocardial infarction, the contrast resolution of MRI is further improved by the addition of extrinsic contrast agents (see myocardial late enhancement).
A dedicated cardiac coil, and a field strength higher than 1 Tesla is recommended to have sufficient signal. Cardiac MRI acquires ECG gating. Cardiac gating (ECGs) obtained within the MRI scanner, can be degraded by the superimposed electrical potential of flowing blood in the magnetic field. Therefore, excellent contact between the skin and ECG leads is necessary. For male patients, the skin at the lead sites can be shaved. A good cooperation of the patient is necessary because breath holding at the end of expiration is practiced during the most sequences.

See also Displacement Encoding with Stimulated Echoes.
For Ultrasound Imaging (USI) see Cardiac Ultrasound at Medical-Ultrasound-Imaging.com.

See also the related poll results: 'In 2010 your scanner will probably work with a field strength of' and 'MRI will have replaced 50% of x-ray exams by'

During the MRI scan an augmentation of T waves is observed at fields used in standard imaging but this possible MRI side effect is completely reversible upon removal from the magnet. A field strength dependent increase in the amplitude of the ECG in rats has been observed during exposure to high homogeneous stationary magnetic fields, but this side effect is not transferable to standard imaging situations for humans.

The minimum level at which augmentation can be observed is 0.3 T and increases by higher field strength. An augmentation in T-wave amplitude can occur instantaneously and is immediately reversible after exposure to the magnetic field ceased. There should be no abnormalities in the ECG in the later follow-up. Augmentation of the signal amplitude in the T-wave segment may result from superimposed electrical potential. No circulatory alterations coincide with the ECG changes. Therefore, no biological risks are believed to be associated with them.

For more MRI safety information see also Contraindications and MRI Risks.